Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2001-3-6
pubmed:abstractText
The proinflammatory cytokine IL-18 was investigated for its role in human myocardial function. An ischemia/reperfusion (I/R) model of suprafused human atrial myocardium was used to assess myocardial contractile force. Addition of IL-18 binding protein (IL-18BP), the constitutive inhibitor of IL-18 activity, to the perifusate during and after I/R resulted in improved contractile function after I/R from 35% of control to 76% with IL-18BP. IL-18BP treatment also preserved intracellular tissue creatine kinase levels (by 420%). Steady-state mRNA levels for IL-18 were elevated after I/R, and the concentration of IL-18 in myocardial homogenates was increased (control, 5.8 pg/mg vs. I/R, 26 pg/mg; P < 0.01). Active IL-18 requires cleavage of its precursor form by the IL-1beta-converting enzyme (caspase 1); inhibition of caspase 1 also attenuated the depression in contractile force after I/R (from 35% of control to 75.8% in treated atrial muscle; P < 0.01). Because caspase 1 also cleaves the precursor IL-1beta, IL-1 receptor blockade was accomplished by using the IL-1 receptor antagonist. IL-1 receptor antagonist added to the perifusate also resulted in a reduction of ischemia-induced contractile dysfunction. These studies demonstrate that endogenous IL-18 and IL-1beta play a significant role in I/R-induced human myocardial injury and that inhibition of caspase 1 reduces the processing of endogenous precursors of IL-18 and IL-1beta and thereby prevents ischemia-induced myocardial dysfunction.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-10023777, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-10051628, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-10210635, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-10446825, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-10471354, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-10655506, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-10681439, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-10690285, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-10728385, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-1631560, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-2203553, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-3826401, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-7536096, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-7558306, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-7856752, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-7943392, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-8331924, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-8628393, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-8642298, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-8752821, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-8999548, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-9054727, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-9121587, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-9236412, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-9325300, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-9354477, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-9485242, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-9545547, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-9698510, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-9792649, http://linkedlifedata.com/resource/pubmed/commentcorrection/11226333-9893178
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
27
pubmed:volume
98
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2871-6
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:11226333-Animals, pubmed-meshheading:11226333-CHO Cells, pubmed-meshheading:11226333-Caspase 1, pubmed-meshheading:11226333-Creatine Kinase, pubmed-meshheading:11226333-Cricetinae, pubmed-meshheading:11226333-Glycoproteins, pubmed-meshheading:11226333-Humans, pubmed-meshheading:11226333-Intercellular Signaling Peptides and Proteins, pubmed-meshheading:11226333-Interleukin 1 Receptor Antagonist Protein, pubmed-meshheading:11226333-Interleukin-1, pubmed-meshheading:11226333-Interleukin-18, pubmed-meshheading:11226333-Microscopy, Confocal, pubmed-meshheading:11226333-Myocardial Ischemia, pubmed-meshheading:11226333-Myocardium, pubmed-meshheading:11226333-RNA, Messenger, pubmed-meshheading:11226333-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:11226333-Sialoglycoproteins
pubmed:year
2001
pubmed:articleTitle
Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta.
pubmed:affiliation
Department of Surgery, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Denver, CO 80262, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.